政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/131050

政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/131050

English | 正體中文 | 简体中文 | Post-Print筆數 : 27 | 全文笔数/总笔数 : 113648/144635 (79%)
造访人次 : 51688443 在线人数 : 632

RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.

搜寻范围

查询小技巧：

您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果

若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据

进阶搜寻

主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于政大典藏 ‧ 管理

到手机版

政大機構典藏 > 商學院 > 國際經營管理英語碩士學程IMBA > 學位論文 > Item 140.119/131050

请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/131050

题名:	企業合併與收購之效益分析 Analysis on the Benefit of the Coherent Mergers and Acquisitions
作者:	林秀琦 Pinitkitjawat, Napassorn
贡献者:	劉助 Liu, James 林秀琦 Napassorn Pinitkitjawat
关键词:	合併與收購必治妥施貴寶賽爾基因收購案合併與收購的利益 Mergers and Acquisitions Bristol Myers Squibb Celgene Acquisition Benefit of Mergers and Acquisitions
日期:	2020
上传时间:	2020-08-03 17:47:17 (UTC+8)
摘要:	With the disruptive technology and the rapid change in the business environment, the current business environment results in a spike in the M&A activity. But is M&A beneficial to companies? Fundamental analysis on the actual financial performance for pre- and post-M&A of the sample M&A case, Bristol Myers Squibb – Celgene Acquisition is conducted to help determine if this business methodology truly bring about benefits to the companies over the study period.
參考文獻:	Arık, E., & Kutan, A. M. (2015). Do Mergers and Acquisitions Create Wealth Effects? Evidence from Twenty Emerging Markets. Eastern European Economics, 53(6), 529–550. https://doi.org/10.1080/00128775.2015.1099445 Bansal, De Backer, and Ranade. (2018, October 10). What’s behind the pharmaceutical sector’s M&A push. Retrieved from https://www.mckinsey.com/business-functions/strategy-and-corporate-finance/our-insights/whats-behind-the-pharmaceutical-sectors-m-and-a-push BRISTOL MYERS SQUIBB drug patent status, international patents. (2020, June 15). Retrieved from https://www.drugpatentwatch.com/p/applicant/Bristol%20Myers%20Squibb Brown, and Elmhirst. (2018, October 3). Few biopharma buyouts in quiet third quarter. Retrieved from https://www.evaluate.com/vantage/articles/data-insights/ma/few-biopharma-buyouts-quiet-third-quarter Celgene: A Winner in Biopharma. (2015, December 10). Retrieved from https://digital.hbs.edu/platform-rctom/submission/celgene-a-winner-in-biopharma/ Hansell, Kotzen, Olsen, and Farag. (2016, October 25). Bristol-Myers Squibb: Reshaping the Portfolio to Create Superior Shareholder Value. Retrieved from https://www.bcg.com/publications/2016/value-creation-strategy-corporate-development-bristol-myers-squibb.aspx Health at a Glance 2019: OECD Indicators \| en \| OECD. (2019, November 7). Retrieved from http://www.oecd.org/health/health-systems/health-at-a-glance-19991312.htm Kengelbach, Keienburg, Gell, Nielsen, Bader, Degen, and Sievers. (2019, September 25). 2019 Mergers & Acquisitions (M&A) Report: Downturns Are a Better Time for Deal Hunting. Retrieved from https://www.bcg.com/publications/2019/mergers-and-acquisitions-report-shows-downturns-are-a-better-time-for-deal-hunting.aspx Lobet and van Gampelaere, F. and C. (2018, February 15). Success and Failure in M&A Execution - An Empirical Study — Retrieved from https://gpmip.com/success-and-failure-in-ma-execution-an-empirical-study/ M. Christensen, Alton, Rising, and Waldeck. (2011, March). The Big Idea: The New M&A Playbook. Retrieved from https://hbr.org/2011/03/the-big-idea-the-new-ma-playbook M. Szmigiera. (2020, February 24). Value of M&A deals globally 1985-2019. Retrieved from https://www.statista.com/statistics/267369/volume-of-mergers-and-acquisitions-worldwide/ Melicher, R. W., & Norton, E. A. (2013). Introduction to Finance (15th ed.). Hoboken, NJ, United States: Wiley. NCHS. (2010, September). Products - Data Briefs - Number 42 - September 2010. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db42.htm PMGroup Worldwide Limited. (2020, April 1). Pharma funding and M&A in 2020. Retrieved from http://www.pmlive.com/pharma_intelligence/Pharma_funding_and_M_and_A_in_2020_1328712 Roser, Ortiz-Ospina and Ritchie. (2019, October). Life Expectancy. Retrieved from https://ourworldindata.org/life-expectancy Taylor, A. (2019, August 22). How to Measure M&A Success. Retrieved from https://hingemarketing.com/blog/story/how-to-measure-ma-success Torjesen, I. (2015, May 12). Drug development: the journey of a medicine from lab to shelf. Retrieved from https://www.pharmaceutical-journal.com/publications/tomorrows-pharmacist/drug-development-the-journey-of-a-medicine-from-lab-to-shelf/20068196.article?firstPass=false Trefis Team. (2019, January 7). Why Is Celgene A Strategic Fit For Bristol-Myers Squibb. Retrieved from https://www.forbes.com/sites/greatspeculations/2019/01/07/why-is-celgene-a-strategic-fit-for-bristol-myers-squibb/#38bc850e76c2 Vitez and Harrison. (2016, December 8). Trends in pharmaceutical mergers and acquisitions. Retrieved from https://biopharmadealmakers.nature.com/users/9880-biopharma-dealmakers/posts/13880-trends-in-pharmaceutical-mergers-and-acquisitions Weintraub, A. (2020, March 26). Bristol Myers nabs long-sought FDA nod for Celgene’s MS drug ozanimod, but pandemic delays launch. Retrieved from https://www.fiercepharma.com/pharma/bristol-myers-investors-breathe-a-sigh-relief-as-fda-approves-celgene-s-ms-drug-ozanimod
描述:	碩士國立政治大學國際經營管理英語碩士學位學程(IMBA) 107933045
資料來源:	http://thesis.lib.nccu.edu.tw/record/#G0107933045
数据类型:	thesis
DOI:	10.6814/NCCU202000993
显示于类别:	[國際經營管理英語碩士學程IMBA] 學位論文

文件中的档案:

档案	描述	大小	格式	浏览次数
304501.pdf		2468Kb	Adobe PDF2	75	检视/开启

在政大典藏中所有的数据项都受到原著作权保护.

社群 sharing

著作權政策宣告 Copyright Announcement

1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.

DSpace Software Copyright © 2002-2004 MIT & Hewlett-Packard / Enhanced by NTU Library IR team Copyright © - 回馈